Skip to main content

Table 2 Characteristics, comorbidities, risk factors, procedures, postoperative complications and in-hospital outcomes in patients underwent SAVR in Spain in 2014/15, according to type 2 diabetes status

From: Transcatheter aortic valve implantation and surgical aortic valve replacement among hospitalized patients with and without type 2 diabetes mellitus in Spain (2014–2015)

 

T2DM

n = 4057

No T2DM

n = 11,956

p value

Female sex, n (%)

1630 (40.18)

5061 (42.33)

0.016

Age, mean (SD)

72.47 (7.76)

70.36 (10.03)

< 0.01

Age groups, n (%)

 40–66 years

828 (20.41)

3562 (29.79)

< 0.01

 67–75 years

1591 (39.22)

3961 (33.13)

 ≥ 76 years

1638 (40.37)

4433 (37.08)

Charlson comorbidity index, mean (SD)a

0.83 (0.9)

0.81 (0.88)

< 0.01

Congestive heart failure, n (%)

711 (17.53)

2229 (18.64)

0.112

Cerebrovascular disease, n (%)

284 (7)

682 (5.7)

0.003

Dementia, n (%)

13 (0.32)

17 (0.14)

0.023

Chronic pulmonary disease, n (%)

798 (19.67)

2295 (19.2)

0.508

Renal disease, n (%)

571 (14.07)

1085 (9.07)

< 0.01

Ischemic heart disease, n (%)

1626 (40.08)

3470 (29.02)

< 0.01

Atrial fibrillation, n (%)

1523 (37.54)

4778 (39.96)

0.006

Intermittent claudication, n (%)

67 (1.65)

80 (0.67)

< 0.01

Endocarditis, n (%)

128 (3.16)

549 (4.59)

< 0.01

Hypertension, n (%)

2731 (67.32)

6094 (50.97)

< 0.01

Lipid metabolism disorders, n (%)

1856 (45.75)

3447 (28.83)

< 0.01

Smoking, n (%)

1041 (25.66)

2920 (24.42)

0.115

Obesity, n (%)

729 (17.97)

1200 (10.04)

< 0.01

Catheterization, n (%)

523 (12.89)

1302 (10.89)

0.001

Computerized tomography of the torax, n (%)

149 (3.67)

629 (5.26)

< 0.01

Magnetic resonance imaging, n (%)

13 (0.32)

45 (0.38)

0.608

Pacemaker device implantation, n (%)

194 (4.78)

551 (4.61)

0.651

Cardioversion, n (%)

205 (5.05)

749 (6.26)

0.005

Balloon counterpulsation, n (%)

55 (1.36)

275 (2.3)

< 0.01

Percutaneous coronary interventions

41 (1.01)

70 (0.59)

0.005

Hemodialysis, n (%)

127 (3.13)

435 (3.64)

0.129

Red blood cell transfusion, n (%)

941 (23.19)

2806 (23.47)

0.721

Infection, n (%)

148 (3.65)

554 (4.63)

0.008

Mediastinitis, n (%)

10 (0.25)

46 (0.38)

0.197

Functional disturbances following SAVR, n (%)

22 (0.54)

101 (0.84)

0.057

Any post procedure complicationb

170 (4.19)

659 (5.51)

0.001

Mortality, n (%)

177 (4.36)

754 (6.31)

< 0.01

Length of stay, mean (SD)

16.37 (13.77)

17.54 (17.27)

< 0.01

Cost, mean (SD)

23,667 (11,994)

24,659 (15,210)

< 0.001

  1. aCCI was calculated excluding DM
  2. bAny post procedure complication included: infection; mediastinitis; and functional disturbances following SAVR